I was expecting… like some others on the board that we would finally hear about our 700mg dose results from our phase 2 Nash trial at these global conferences on Nash. I wonder if the new management is purposely holding back this information for our results and won’t release them this next month in June at these conference’s.

Maybe the Big Bang for our buck wont be realized for this indication and would lack the ability to move the needle if we are still awaiting the Safety aggregate of all trials to be approved by the FDA and commencement or ability of our current and new trials to actually start again. It’s like having the green light for us to move forward approved essentially.

Why would we announce such a big news event if it is as great as we expect it to be? If investors do their due diligence and see we have clinical holds on our trials currently? Maybe after our 8-12 month estimated safety look and then maybe a month longer for FDA viewing the the process approval. Does this add up to End of July or August? Then we drop the bomb of great 700mg Nash results when they will actually have the biggest bang for the buck?

What does anyone think about this scenario? Likely? Not likely and we reveal results while in clinical hold? No way we hold back these results any longer because a partner is imminent or will be announced?